Observation of B0-->D*sJ(2317)+K- decay.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 15783721)

Published in Phys Rev Lett on February 16, 2005

Authors

A Drutskoy1, K Abe, K Abe, I Adachi, H Aihara, M Akatsu, Y Asano, T Aushev, S Bahinipati, A M Bakich, A Bay, I Bedny, U Bitenc, I Bizjak, S Blyth, A Bondar, A Bozek, M Bracko, J Brodzicka, T E Browder, P Chang, Y Chao, A Chen, K-F Chen, W T Chen, B G Cheon, R Chistov, S-K Choi, Y Choi, A Chuvikov, S Cole, J Dalseno, M Danilov, M Dash, S Eidelman, V Eiges, Y Enari, F Fang, S Fratina, N Gabyshev, T Gershon, A Go, G Gokhroo, B Golob, K Hayasaka, H Hayashii, M Hazumi, T Higuchi, L Hinz, T Hokuue, Y Hoshi, S Hou, W-S Hou, A Imoto, K Inami, A Ishikawa, M Iwasaki, Y Iwasaki, J H Kang, J S Kang, P Kapusta, N Katayama, H Kawai, T Kawasaki, H R Khan, H Kichimi, H J Kim, J H Kim, S K Kim, S M Kim, K Kinoshita, P Koppenburg, P Krizan, P Krokovny, R Kulasiri, C C Kuo, A Kuzmin, Y-J Kwon, J S Lange, S H Lee, T Lesiak, J Li, S-W Lin, D Liventsev, J MacNaughton, G Majumder, F Mandl, T Matsumoto, A Matyja, Y Mikami, W Mitaroff, H Miyata, R Mizuk, D Mohapatra, T Mori, T Nagamine, Y Nagasaka, E Nakano, M Nakao, H Nakazawa, Z Natkaniec, S Nishida, O Nitoh, S Ogawa, T Ohshima, T Okabe, S L Olsen, W Ostrowicz, H Ozaki, P Pakhlov, H Palka, C W Park, H Park, N Parslow, R Pestotnik, L E Piilonen, M Rozanska, H Sagawa, Y Sakai, N Sato, T Schietinger, O Schneider, P Schönmeier, J Schümann, A J Schwartz, S Semenov, K Senyo, R Seuster, H Shibuya, A Somov, N Soni, R Stamen, S Stanic, M Staric, K Sumisawa, T Sumiyoshi, S Suzuki, S Y Suzuki, O Tajima, F Takasaki, K Tamai, N Tamura, M Tanaka, Y Teramoto, X C Tian, T Tsukamoto, S Uehara, T Uglov, K Ueno, S Uno, S Villa, C C Wang, C H Wang, M-Z Wang, M Watanabe, B D Yabsley, A Yamaguchi, Y Yamashita, M Yamauchi, J Ying, C C Zhang, L M Zhang, Z P Zhang, V Zhilich, D Zontar, Belle Collaboration

Author Affiliations

1: University of Cincinnati, Cincinnati, Ohio 45221, USA.

Articles by these authors

(truncated to the top 100)

The transcriptional landscape of the mammalian genome. Science (2005) 37.63

Nanowire nanosensors for highly sensitive and selective detection of biological and chemical species. Science (2001) 10.93

The effect of adrenalin on the gaseous metabolism of the isolated mammalian heart. J Physiol (1914) 8.89

Monoclonal antibodies to Chlamydia trachomatis: antibody specificities and antigen characterization. J Immunol (1982) 8.61

A new Chlamydia psittaci strain, TWAR, isolated in acute respiratory tract infections. N Engl J Med (1986) 8.03

Stroke incidence and survival among middle-aged adults: 9-year follow-up of the Atherosclerosis Risk in Communities (ARIC) cohort. Stroke (1999) 7.93

Trends in the incidence of myocardial infarction and in mortality due to coronary heart disease, 1987 to 1994. N Engl J Med (1998) 7.12

Studies on the mechanism by which cyanine dyes measure membrane potential in red blood cells and phosphatidylcholine vesicles. Biochemistry (1974) 6.97

Blockade of RAGE-amphoterin signalling suppresses tumour growth and metastases. Nature (2000) 6.70

A new respiratory tract pathogen: Chlamydia pneumoniae strain TWAR. J Infect Dis (1990) 6.52

Enzymatic methods for the determination of small quantities of isomeric chondroitin sulfates. J Biol Chem (1968) 6.28

Culture-independent diagnosis of Chlamydia trachomatis using monoclonal antibodies. N Engl J Med (1984) 6.08

Purification and properties of bacterial chondroitinases and chondrosulfatases. J Biol Chem (1968) 5.66

Cardiomyocytes can be generated from marrow stromal cells in vitro. J Clin Invest (1999) 5.30

Immunotyping of Chlamydia trachomatis with monoclonal antibodies. J Infect Dis (1985) 5.29

ER stress (PERK/eIF2alpha phosphorylation) mediates the polyglutamine-induced LC3 conversion, an essential step for autophagy formation. Cell Death Differ (2006) 5.18

Angiopoietin-1 regulates endothelial cell survival through the phosphatidylinositol 3'-Kinase/Akt signal transduction pathway. Circ Res (2000) 4.97

Long non-coding RNA ANRIL is required for the PRC2 recruitment to and silencing of p15(INK4B) tumor suppressor gene. Oncogene (2010) 4.81

Mucopurulent cervicitis--the ignored counterpart in women of urethritis in men. N Engl J Med (1984) 4.74

Antigenic modulation. Loss of TL antigen from cells exposed to TL antibody. Study of the phenomenon in vitro. J Exp Med (1968) 4.63

Monitoring community responses to the SARS epidemic in Hong Kong: from day 10 to day 62. J Epidemiol Community Health (2003) 4.45

The genome sequence of Bifidobacterium longum subsp. infantis reveals adaptations for milk utilization within the infant microbiome. Proc Natl Acad Sci U S A (2008) 4.45

Functional tissue engineering of articular cartilage through dynamic loading of chondrocyte-seeded agarose gels. J Biomech Eng (2000) 4.22

Subset of individuals with autism spectrum disorders and extreme macrocephaly associated with germline PTEN tumour suppressor gene mutations. J Med Genet (2005) 4.14

Amino acid sequence of the human fibronectin receptor. J Cell Biol (1987) 4.08

Catechol-O-methyltransferase-deficient mice exhibit sexually dimorphic changes in catecholamine levels and behavior. Proc Natl Acad Sci U S A (1998) 3.99

MR imaging of metronidazole-induced encephalopathy: lesion distribution and diffusion-weighted imaging findings. AJNR Am J Neuroradiol (2007) 3.95

Repression of E-cadherin by the polycomb group protein EZH2 in cancer. Oncogene (2008) 3.92

Crystal structure of a pol alpha family replication DNA polymerase from bacteriophage RB69. Cell (1997) 3.89

A novel signaling molecule, p130, forms stable complexes in vivo with v-Crk and v-Src in a tyrosine phosphorylation-dependent manner. EMBO J (1994) 3.88

Fission yeast cut3 and cut14, members of a ubiquitous protein family, are required for chromosome condensation and segregation in mitosis. EMBO J (1994) 3.83

Changes in axon fluorescence during activity: molecular probes of membrane potential. J Membr Biol (1974) 3.80

Olfactory neuroblastoma. A clinical analysis of 17 cases. Cancer (1976) 3.79

Iron transport in Escherichia coli: roles of energy-dependent uptake and 2,3-dihydroxybenzoylserine. J Bacteriol (1969) 3.75

Sensitivity of immunofluorescence with monoclonal antibodies for detection of Chlamydia trachomatis inclusions in cell culture. J Clin Microbiol (1982) 3.64

Further Studies in Adult Rickets (Osteomalacia) and Foetal Rickets: (Section of Obstetrics and Gynaecology). Proc R Soc Med (1939) 3.56

Importance of reinfection in the pathogenesis of trachoma. Rev Infect Dis (1986) 3.50

Generation of single optical plasmons in metallic nanowires coupled to quantum dots. Nature (2007) 3.50

Changes in absorption, fluorescence, dichroism, and Birefringence in stained giant axons: : optical measurement of membrane potential. J Membr Biol (1977) 3.49

Association of BRCA1 with the hRad50-hMre11-p95 complex and the DNA damage response. Science (1999) 3.47

Effect of polycations, polyanions and neuraminidase on the infectivity of trachoma-inclusin conjunctivitis and lymphogranuloma venereum organisms HeLa cells: sialic acid residues as possible receptors for trachoma-inclusion conjunction. Infect Immun (1973) 3.46

Interaction of Chlamydia trachomatis organisms and HeLa 229 cells. Infect Immun (1976) 3.44

Antigenic analysis of Chlamydiae by two-dimensional immunoelectrophoresis. I. Antigenic heterogeneity between C. trachomatis and C. psittaci. J Immunol (1975) 3.41

Antimicrobial activity of several antibiotics and a sulfonamide against Chlamydia trachomatis organisms in cell culture. Antimicrob Agents Chemother (1977) 3.34

A Method for Estimating Volume-Surface Ratios. Science (1949) 3.31

Correlation of host immune response with quantitative recovery of Chlamydia trachomatis from the human endocervix. Infect Immun (1983) 3.22

Current knowledge on Chlamydia pneumoniae, strain TWAR, an important cause of pneumonia and other acute respiratory diseases. Eur J Clin Microbiol Infect Dis (1989) 3.15

Cellular applications of 31P and 13C nuclear magnetic resonance. Science (1979) 3.14

Neurological response to early removal of ovarian teratoma in anti-NMDAR encephalitis. J Neurol Neurosurg Psychiatry (2007) 3.12

Identification of a new group of Chlamydia psittaci strains called TWAR. J Clin Microbiol (1986) 3.11

Comparative analysis of the HTLV-I Rex and HIV-1 Rev trans-regulatory proteins and their RNA response elements. Genes Dev (1989) 3.09

Epidural spinal cord compression from metastatic tumor: diagnosis and treatment. Ann Neurol (1978) 3.08

Structural basis for the activation of 20S proteasomes by 11S regulators. Nature (2000) 3.04

Pneumonia associated with the TWAR strain of Chlamydia. Ann Intern Med (1987) 3.00

A strain-driven morphotropic phase boundary in BiFeO3. Science (2009) 2.95

A simplified method for immunological typing of trachoma-inclusion conjunctivitis-lymphogranuloma venereum organisms. Infect Immun (1973) 2.93

Detection of Chlamydia pneumoniae TWAR in human coronary atherectomy tissues. J Infect Dis (1995) 2.90

Iron transport in Escherichia coli: relationship between chromium sensitivity and high iron requirement in mutants of Escherichia coli. J Bacteriol (1969) 2.89

DTI and MTR abnormalities in schizophrenia: analysis of white matter integrity. Neuroimage (2005) 2.84

An additional step in the transport of iron defined by the tonB locus of Escherichia coli. J Biol Chem (1971) 2.82

Characterization of the new Chlamydia agent, TWAR, as a unique organism by restriction endonuclease analysis and DNA-DNA hybridization. J Clin Microbiol (1987) 2.78

Immunotypes of Chlamydia trachomatis isolates in Seattle, Washington. Infect Immun (1983) 2.76

High resolution 31P nuclear magnetic resonance studies of intact yeast cells. Proc Natl Acad Sci U S A (1975) 2.72

Solution structure of the homodimeric core domain of Escherichia coli histidine kinase EnvZ. Nat Struct Biol (1999) 2.72

Activation of BTK by a phosphorylation mechanism initiated by SRC family kinases. Science (1996) 2.71

Identification of amino acid residues in CD81 critical for interaction with hepatitis C virus envelope glycoprotein E2. J Virol (2000) 2.71

Standardizing Chlamydia pneumoniae assays: recommendations from the Centers for Disease Control and Prevention (USA) and the Laboratory Centre for Disease Control (Canada). Clin Infect Dis (2001) 2.71

NMR structure of the histidine kinase domain of the E. coli osmosensor EnvZ. Nature (1998) 2.69

Complete amino acid sequence of human vitronectin deduced from cDNA. Similarity of cell attachment sites in vitronectin and fibronectin. EMBO J (1985) 2.69

Scheduling of revaccination against hepatitis B virus. Lancet (1991) 2.65

Thoracic pedicle screw fixation in spinal deformities: are they really safe? Spine (Phila Pa 1976) (2001) 2.64

Unique ultrastructure in the elementary body of Chlamydia sp. strain TWAR. J Bacteriol (1987) 2.61

High-resolution 31P nuclear magnetic resonance studies of metabolism in aerobic Escherichia coli cells. Proc Natl Acad Sci U S A (1977) 2.58

cDNA and amino acid sequences of the cell adhesion protein receptor recognizing vitronectin reveal a transmembrane domain and homologies with other adhesion protein receptors. Proc Natl Acad Sci U S A (1986) 2.58

Enhanced expression of Iba1, ionized calcium-binding adapter molecule 1, after transient focal cerebral ischemia in rat brain. Stroke (2001) 2.51

Hippocampal interneuron loss and plasticity in human temporal lobe epilepsy. Brain Res (1989) 2.51

Detection of Chlamydia pneumoniae by polymerase chain reaction. J Clin Microbiol (1992) 2.49

Comparative susceptibility of eleven mammalian cell lines to infection with trachoma organisms. J Clin Microbiol (1975) 2.48

Deficiency of T2K leads to apoptotic liver degeneration and impaired NF-kappaB-dependent gene transcription. EMBO J (2000) 2.48

Loss of glutamine synthetase in the human epileptogenic hippocampus: possible mechanism for raised extracellular glutamate in mesial temporal lobe epilepsy. Lancet (2004) 2.47

An intracellular protein that binds amyloid-beta peptide and mediates neurotoxicity in Alzheimer's disease. Nature (1997) 2.42

Autonomic and antiarrhythmic drug modulation of ST segment elevation in patients with Brugada syndrome. J Am Coll Cardiol (1996) 2.42

Antigen-specific human antibodies from mice comprising four distinct genetic modifications. Nature (1994) 2.39

Identification and Estimation of Catabolic Pathways of Glucose in Fruits. Plant Physiol (1958) 2.39

Increased frequency of serum antibodies to Chlamydia trachomatis in infertility due to distal tubal disease. Lancet (1982) 2.38

Pattern electrical stimulation of the human retina. Vision Res (1999) 2.35

Improvements in optical methods for measuring rapid changes in membrane potential. J Membr Biol (1981) 2.34

Metabotropic glutamate receptor subtypes 1 and 5 are activators of extracellular signal-regulated kinase signaling required for inflammatory pain in mice. J Neurosci (2001) 2.32

Angiopoietin-2 at high concentration can enhance endothelial cell survival through the phosphatidylinositol 3'-kinase/Akt signal transduction pathway. Oncogene (2000) 2.32

Hepatitis C virus particle detected by immunoelectron microscopic study. J Gen Virol (1994) 2.28

Detection of Chlamydia pneumoniae in coronary arterial fatty streaks and atheromatous plaques. S Afr Med J (1992) 2.28

Tumor necrosis factor induces Bcl-2 and Bcl-x expression through NFkappaB activation in primary hippocampal neurons. J Biol Chem (1999) 2.27

THE OCCURRENCE OF CONJUGATION IN PARAMECIUM CALKINSI. Science (1928) 2.26

The absence of "heme-heme" interactions in hemoglobin. Science (1969) 2.26

Human Tra2 proteins are sequence-specific activators of pre-mRNA splicing. Cell (1998) 2.25

Arginine-glycine-aspartic acid adhesion receptors. Methods Enzymol (1987) 2.25

Chlamydia pneumoniae (TWAR) in atherosclerosis of the carotid artery. Circulation (1995) 2.24

Molecular cloning and expression of Chlamydia trachomatis major outer membrane protein antigens in Escherichia coli. Infect Immun (1985) 2.24

Hospital care by hospital-based and clinic-based faculty: a prospective, controlled trial. Arch Intern Med (2001) 2.23

Cost-effectiveness analysis of sofosbuvir plus peginterferon/ribavirin in the treatment of chronic hepatitis C virus genotype 1 infection. Aliment Pharmacol Ther (2014) 2.22